296 related articles for article (PubMed ID: 23523101)
1. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro.
Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC
Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.
He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R
J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
9. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.
Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H
Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A.
Wang C; Huang Q; Wang C; Zhu X; Duan Y; Yuan S; Bai X
Toxicol Appl Pharmacol; 2013 Nov; 272(3):895-904. PubMed ID: 23933165
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
Tian J; Li G; Liu Z; Fu F
Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
[TBL] [Abstract][Full Text] [Related]
13. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
Cheng Y; Ping J; Xu LM
Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
17. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
Song Y; Long L; Zhang N; Liu Y
Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor Yellow A Shows Protection against PPAR
Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
